Stocks and Investing
Stocks and Investing
Thu, January 25, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Justin Kim Initiated (VERA) at Buy and Held Target at $26 on, Jan 25th, 2024
Justin Kim of Oppenheimer, Initiated "Vera Therapeutics, Inc." (VERA) at Buy and Held Target at $26 on, Jan 25th, 2024.
Justin has made no other calls on VERA in the last 4 months.
There are 5 other peers that have a rating on VERA. Out of the 5 peers that are also analyzing VERA, 0 agree with Justin's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Justin
- Pete Stavropoulos of "Cantor Fitzgerald" Initiated at Buy on, Monday, January 8th, 2024
- Ed Arce of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $25 on, Wednesday, December 27th, 2023
- Steven Seedhouse of "Raymond James" Initiated at Buy and Held Target at $29 on, Monday, December 18th, 2023
- Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $22 on, Thursday, November 30th, 2023
- Farzin Haque of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $26 on, Friday, November 10th, 2023
Contributing Sources